John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$1.41B |
| 2 |
AbbVie
ABBV
|
+$722M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$496M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$323M |
| 5 |
PETM
PETSMART INC
PETM
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$381M |
| 2 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$213M |
| 3 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$208M |
| 4 |
Freeport-McMoran
FCX
|
+$193M |
| 5 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.38% |
| 2 | Communication Services | 17.45% |
| 3 | Energy | 9.96% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Financials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
1
DELISTED
Shire pic
SHPG
| $2.34B | 9.73% |
9,046,000
+5,679,461
| +169% | +$1.41B |
|
2
SPDR Gold Trust
GLD
$152B
| $1.19B | 4.94% |
10,234,852
| – | – |
|
|
STAY
3
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $1.13B | 4.7% |
47,661,591
-8,050,000
| -14% | -$187M |
|
|
COV
4
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $1.09B | 4.52% |
12,595,000
+5,595,000
| +80% | +$496M |
|
|
TWC
5
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $1.05B | 4.37% |
7,325,600
+2,177,260
| +42% | +$323M |
|
|
AGN
6
DELISTED
Allergan Inc
AGN
| $958M | 3.98% |
5,377,200
-224,800
| -4% | -$37.3M |
|
|
DTV
7
DELISTED
DIRECTV COM STK (DE)
DTV
| $900M | 3.74% |
10,400,000
+400,000
| +4% | +$34.4M |
|
8
Vodafone
VOD
$36.9B
| $878M | 3.65% |
26,703,108
-4,300
| -0% | -$143K |
|
|
MNK
9
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $811M | 3.37% |
9,000,000
+2,275,200
| +34% | +$178M |
|
|
10
AbbVie
ABBV
$468B
| $751M | 3.12% |
+13,000,000
| New | +$722M |
|
|
WLL
11
DELISTED
Whiting Petroleum Corporation
WLL
| $725M | 3.01% |
31,151
-340
| -1% | -$8.67M |
|
|
GRFS
12
Grifois
GRFS
$5.44B
| $689M | 2.86% |
39,209,962
-400
| -0% | -$7.77K |
|
|
AET
13
DELISTED
Aetna Inc
AET
| $631M | 2.62% |
7,794,638
-194,868
| -2% | -$15.9M |
|
|
HMHC
14
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $601M | 2.5% |
30,912,558
| – | – |
|
|
CIE
15
DELISTED
Cobalt International Energy, Inc
CIE
| $569M | 2.36% |
2,790,307
+59,234
| +2% | +$13.7M |
|
16
Viatris
VTRS
$18.7B
| $568M | 2.36% |
12,494,700
+364,000
| +3% | +$17.7M |
|
17
MGM Resorts International
MGM
$11B
| $512M | 2.13% |
22,477,000
-9,500
| -0% | -$236K |
|
18
Equinix
EQIX
$105B
| $462M | 1.92% |
2,172,400
+85,400
| +4% | +$18.3M |
|
|
HOUS
19
DELISTED
Anywhere Real Estate
HOUS
| $446M | 1.85% |
12,000,000
| – | – |
|
20
T-Mobile US
TMUS
$196B
| $434M | 1.8% |
15,017,800
+1,860,000
| +14% | +$57.2M |
|
21
HCA Healthcare
HCA
$92.9B
| $428M | 1.78% |
6,069,600
+2,666,981
| +78% | +$176M |
|
|
FDO
22
DELISTED
FAMILY DOLLAR STORES
FDO
| $419M | 1.74% |
5,427,000
-2,593,000
| -32% | -$191M |
|
23
Chord Energy
CHRD
$8.09B
| $413M | 1.72% |
9,889,200
-3,300
| -0% | -$164K |
|
|
S
24
DELISTED
Sprint Corporation
S
| $406M | 1.69% |
64,113,200
| – | – |
|
25
Verizon
VZ
$205B
| $375M | 1.56% |
7,500,000
-1,242,725
| -14% | -$61.8M |
|
Similar funds
John Paulson's Q3 2014 Portfolio in Review
As of Q3 2014, John Paulson held 89 positions worth $24.1B, up 4.4% from $23.1B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
John Paulson deployed $2.08B of net new capital in Q3 2014, opening 7 new positions and adding to 17 existing holdings. Its largest new stake was AbbVie: 13,000,000 shares worth $751M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 23% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was FAMILY DOLLAR STORES, an estimated $191M trimmed.
- John Paulson's largest Q3 2014 buy was AbbVie: 13,000,000 shares worth $751M.
- John Paulson added most to Shire pic in Q3 2014, an estimated $1.41B increase.
- John Paulson's biggest Q3 2014 reduction was FAMILY DOLLAR STORES, cutting an estimated $191M.
- John Paulson fully exited Thermo Fisher Scientific in Q3 2014, selling an estimated $381M.
- John Paulson's ten largest holdings make up 46% of its $24.1B portfolio in Q3 2014.
- John Paulson opened 7 new positions and closed 14 in Q3 2014.
- John Paulson's portfolio value rose 4.4% quarter-over-quarter to $24.1B.
Based on Paulson & Co's 13F filing for Q3 2014, filed 14 Nov 2014.